Search

everythinglearnresearchcommunity

for

Search:↓

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Finasteride, often used for hair loss, can potentially cause cataracts.